Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2010
12/16/2010WO2010089756A3 An improved process for pegylation of proteins
12/16/2010WO2010046377A3 Immunoactivating conjugates comprising nanoparticles coated with peptides
12/16/2010WO2009143280A3 Nanolipoprotein particles and related compositions, methods and systems
12/16/2010WO2009129281A3 Compositions and methods for delivering inhibitory oligonucleotides
12/16/2010US20100317746 Improved isomalt-containing tablets and methods for the production thereof
12/16/2010US20100317745 Bioresorbable Polymers
12/16/2010US20100317631 Gel Composition and Transcrotal Application of a Composition for the Treatment of Hypogonadism
12/16/2010US20100317609 Method of Producing Hydroxyalkyl Starch Derivatives
12/16/2010US20100317586 Method for topical treatment of eye disease and composition and device for said treatment
12/16/2010US20100317574 Diketopiperazine Microparticles with Defined Isomer Contents
12/16/2010US20100316768 Nutritionally Fortified Liquid Composition With Added Value Delivery Systems/Elements/Additives
12/16/2010US20100316721 Granular Sustained Release Preparation and Production Thereof
12/16/2010US20100316715 Chitosan composition
12/16/2010US20100316710 Sustained-release tablet composition of pramipexole
12/16/2010US20100316657 Synthetic Archaeal Glycolipid Adjuvants
12/16/2010US20100316602 Compositions and methods for treatment of angiogenesis in pathological lesions
12/16/2010US20100316585 Use of Magnesium Stearate Dihydrate for Lubrication of Solid Industrial or Consumer Products
12/16/2010DE102009025549A1 Zusammensetzung für den Transport von Orotsäure über die Bluthirnschranke Composition for the transport of orotic acid across the blood brain barrier
12/16/2010CA2801842A1 Amorphous varenicline tartrate co-precipitates
12/16/2010CA2765233A1 Ipamorelin diacetate injection and infusion solutions
12/16/2010CA2765156A1 Diketopiperazine microparticles with defined isomer contents
12/16/2010CA2764872A1 Hemoglobin compositions
12/16/2010CA2764828A1 Hydrophobins for dispersing active agents
12/16/2010CA2764777A1 Fusion proteins for delivery of gdnf and bdnf to the central nervous system
12/16/2010CA2763923A1 Semi-solid compositions and pharmaceutical products
12/16/2010CA2763837A1 Solid compositions comprising 5-aminolevulinic acid
12/16/2010CA2688766A1 Compositions and methods for treatment of multiple sclerosis
12/15/2010EP2261263A1 Processed starch powder with excellent disintegration properties and manufacturing method thereof
12/15/2010EP2261200A2 Modified forms of pharmacacologically active agents and uses therefor
12/15/2010EP2260875A2 Folate-receptor targeted imaging agents
12/15/2010EP2260874A1 Aprotinin analogs as carriers across the blood-brain barrier
12/15/2010EP2260873A1 Pcylation of proteins
12/15/2010EP2260872A2 Polymer conjugates of interferon beta-1A and uses thereof
12/15/2010EP2260871A2 Inclusion complexes comprising piroxicam, a cyclodextrin and arginine
12/15/2010EP2260858A2 Monomethylvaline compounds capable of conjugation to ligands
12/15/2010EP2260853A2 Biocompatible polymers for a medical composition
12/15/2010EP2260852A2 Bisphosphonate conjugates and methods of making and using the same
12/15/2010EP2260848A1 Aqueous liquid containing gatifloxacin, method for production thereof, and method for prevention of production of precipitates during storage of the aqueous liquid at low temperature or upon freezing/thawing of the aqueous liquid
12/15/2010EP2260847A1 Aqueous liquid containing gatifloxacin
12/15/2010EP2260836A2 Rapid release tablet with coated drug-containing core and surrounding taste masking layer
12/15/2010EP2260835A2 Composition for proteasome inhibition
12/15/2010EP2260834A2 Granular sustained release preparation and production thereof
12/15/2010EP2260833A2 Bilayer pharmaceutical tablet comprising telmisartan and a diuretic
12/15/2010EP2260832A2 Optimal polymer mixtures for gastric retentive tablets
12/15/2010EP2260725A2 Process for Preparing Concentrate Thickener Compositions
12/15/2010EP2260724A2 Process for preparing concentrate thickener compositions
12/15/2010EP2260723A2 Process for Preparing Concentrate Thickener Compositions
12/15/2010EP2260722A2 Process for Preparing Concentrate Thickener Compositions
12/15/2010EP2259802A1 Drug fusions and conjugates
12/15/2010EP2259801A1 Stable pharmaceutical compositions of carvedilol
12/15/2010EP2259798A1 Compositions and methods for drug delivery
12/15/2010EP2259789A2 Pharmaceutical kit consisting of an oil-in-water emulsion and a solid composition
12/15/2010EP2259784A1 Composition and method for irrigation of a prepared dental root canal
12/15/2010EP2259780A2 Pharmaceutical composition comprising naltrexone
12/15/2010EP2259775A2 System for delivery of protein in insoluble fibrillar or aggregate form
12/15/2010EP1948231B1 Composition comprising a colloidal synthetic bioresorbable vector and a viral vector
12/15/2010EP1814558B1 Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
12/15/2010EP1802295B1 Oral pharmaceutical composition for targeted transport of a platinum complex into the colorectal region, method for producing and use as medicament thereof
12/15/2010EP1768700B1 Conjugates comprising gm-csf and a polymer
12/15/2010EP1758591B2 Invert emulsion composition containing calcitriol and clobetasol 17-propionate, and uses thereof in cosmetics and dermatology
12/15/2010EP1755666B1 Vaccine compositions comprising virosomes and a saponin adjuvant
12/15/2010EP1694709B1 Recombinant anti-cd64-eta' immunotoxins
12/15/2010EP1539818B1 Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells
12/15/2010EP1537146B1 Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections
12/15/2010EP1404174B1 Anti-infective compositions for treating disordered tissue such as cold sores
12/15/2010CN1993138B Method of stabilizing proteins
12/15/2010CN1968678B External preparation for the skin
12/15/2010CN1946394B Injectable composition for the treatment of cancers
12/15/2010CN1889942B Drug containing (2R)-2-propyloctanoic acid as the active ingredient
12/15/2010CN1883456B Flavor-hidden pharmaceutical granule, preparation method and use thereof
12/15/2010CN1867359B Methylphenidate solution and its pharmaceutical uses and production
12/15/2010CN1816325B Hydrophilic adhesives for delivery of herbal medicines
12/15/2010CN1780596B Random and non-random alkylene oxide polymer alloy compositions
12/15/2010CN1723872B Oil-in-water emulsified composition
12/15/2010CN1547475B Dermal therapy using phosphate derivatives of electron transfer agents
12/15/2010CN101918455A Hydroxyalkyl starch derivatives and process for their preparation
12/15/2010CN101918454A Method for producing a hydroxyalkyl starch derivative with two linkers
12/15/2010CN101918033A Increase of immune response and targeting by antigens and/or drug linkage
12/15/2010CN101918032A Cross-linked hydrogel containing an active substance
12/15/2010CN101918031A Skin external preparation
12/15/2010CN101918002A Methods and compositions for treating intervertebral disc herniations
12/15/2010CN101917978A Pharmaceutical formulations
12/15/2010CN101917969A Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers
12/15/2010CN101917968A Dexamethasone formulations in a biodegradable material
12/15/2010CN101917967A Pharmaceutical compositions containing at least one proteinaceous active ingredient protected against digestive enzymes
12/15/2010CN101917962A Microparticle film composition
12/15/2010CN101914816A Ferulic acid glyceryl oleate polyvinylpyrrolidone nanometer fiber membrane and preparation and application thereof
12/15/2010CN101914226A Method for preparing chitosan/attapulgite composite material for medicament sustained release
12/15/2010CN101914225A Method for preparing hyaluronic acid gel by using macromolecule photocrosslinking agent
12/15/2010CN101914212A Method for preparing pharmaceutical adjuvant-croscarmellose sodium from sodium carboxymethylcellulose by solvent method
12/15/2010CN101914199A Polyester and preparation method thereof
12/15/2010CN101914198A TPGS-b-(PCL-ran-PGA) copolymer and preparation method and application thereof
12/15/2010CN101914168A Medical applications and preparation methods of Pleurotus ferulae Lanzi polysaccharide and composites thereof
12/15/2010CN101914161A Fusion protein HGF alpha-Fc for restraining tumor growth and application thereof
12/15/2010CN101914158A Anti-cd20 antibodies and fusion proteins thereof and methods of use
12/15/2010CN101912616A Alpha-tocopheryl mesoporous silicon compound using supercritical CO2 injection method and preparation method thereof
12/15/2010CN101912615A Cladribine formulations for improved oral and transmucosal delivery
12/15/2010CN101912614A Pellets or fine granules assisting oral administration and preparation technology thereof
12/15/2010CN101912613A Taste masking preparation
12/15/2010CN101912609A Composition for preventing and controlling pseudomonas aeruginosa infection and preparation method thereof
1 ... 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 ... 1712